FA
FATE
Fate Therapeutics Inc
$2.34
1M -7.1%
3M +13.6%
YTD +136.4%
as of 2026-09-14
+Watchlist
↑↓ next ticker
· ⌘+↑↓ or scroll to zoom
· ←→ pan · 0 reset
▲ buy
▼ sell · size ≈ trade size
· ─ moving averages ·
click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Seasonality
Weak window historically
Next 30 days (to Oct 15): -12.1% median,
25% of the last 12 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 42
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is +0.11%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.91 -0.9% · Seasonal tilt -0.2%
$3M/day volume
96% volatility
+129% 1-year
52-week range · 61% of the way up · -28% from the high
$0.94$3.23
Congressional trades in FATE
Full tracker →
1 member · 0 buys / 1 sells
· $1K–$15K disclosed · latest filing Feb 24, 2023.
| SELL |
DG Daniel Goldman
· traded Jan 31, 2023 |
$1K–$15K |
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.